PUMA BIOTECHNOLOGY, INC. Net Income (Loss) Available to Common Stockholders, Basic
PUMA BIOTECHNOLOGY, INC. (PBYI) reported Net Income (Loss) Available to Common Stockholders, Basic of -$14.99 million for the 3-month period ending 2020-12-31, per its 10-K filed 2021-03-01.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2021-03-01
- PUMA BIOTECHNOLOGY, INC. net income (loss) available to common stockholders, basic for the quarter ending 2020-12-31 was -$14.99M.
- PUMA BIOTECHNOLOGY, INC. net income (loss) available to common stockholders, basic for the quarter ending 2020-09-30 was -$31.46M.
- PUMA BIOTECHNOLOGY, INC. net income (loss) available to common stockholders, basic for the quarter ending 2020-06-30 was $3.40M.
- PUMA BIOTECHNOLOGY, INC. net income (loss) available to common stockholders, basic for the quarter ending 2020-03-31 was -$16.93M.
- PUMA BIOTECHNOLOGY, INC. net income (loss) available to common stockholders, basic for fiscal 2020 was -$59.99M.
- PUMA BIOTECHNOLOGY, INC. net income (loss) available to common stockholders, basic for fiscal 2019 was -$75.59M.
- PUMA BIOTECHNOLOGY, INC. net income (loss) available to common stockholders, basic for fiscal 2018 was -$113.58M.
- PUMA BIOTECHNOLOGY, INC. net income (loss) available to common stockholders, basic for fiscal 2017 was -$291.95M.
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 3 month | Net Income (Loss) Available to Common Stockholders, Basic 3 month as first filed | Net Income (Loss) Available to Common Stockholders, Basic 4 month | Net Income (Loss) Available to Common Stockholders, Basic 6 month | Net Income (Loss) Available to Common Stockholders, Basic 6 month as first filed | Net Income (Loss) Available to Common Stockholders, Basic 9 month | Net Income (Loss) Available to Common Stockholders, Basic 9 month as first filed | Net Income (Loss) Available to Common Stockholders, Basic 12 month | Net Income (Loss) Available to Common Stockholders, Basic 12 month as first filed | Net Income (Loss) Available to Common Stockholders, Basic 16 month | Net Income (Loss) Available to Common Stockholders, Basic 18 month | Net Income (Loss) Available to Common Stockholders, Basic 21 month | Net Income (Loss) Available to Common Stockholders, Basic 25 month | Net Income (Loss) Available to Common Stockholders, Basic 27 month | Net Income (Loss) Available to Common Stockholders, Basic 30 month | Net Income (Loss) Available to Common Stockholders, Basic 33 month | Net Income (Loss) Available to Common Stockholders, Basic 36 month | Net Income (Loss) Available to Common Stockholders, Basic 39 month | Net Income (Loss) Available to Common Stockholders, Basic 42 month | Net Income (Loss) Available to Common Stockholders, Basic 45 month | Net Income (Loss) Available to Common Stockholders, Basic 48 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020-12-31 | -$14.99M 10-K · filed 2021-03-01 | -$46.46M derived: sum of 2 quarters · filed 2021-03-01 | -$43.06M derived: sum of 3 quarters · filed 2021-03-01 | -$59.99M 10-K · filed 2021-03-01 | |||||||||||||||||
| 2020-09-30 | -$31.46M 10-K · filed 2021-03-01 | -$28.07M derived: sum of 2 quarters · filed 2021-03-01 | -$45.00M 10-Q · filed 2020-11-05 | -$56.20M derived: sum of 4 quarters · filed 2021-03-01 | |||||||||||||||||
| 2020-06-30 | $3.40M 10-K · filed 2021-03-01 | -$13.54M 10-Q · filed 2020-08-06 | -$24.74M derived: sum of 3 quarters · filed 2021-03-01 | -$41.62M derived: sum of 4 quarters · filed 2021-03-01 | |||||||||||||||||
| 2020-03-31 | -$16.93M 10-K · filed 2021-03-01 | -$28.13M derived: sum of 2 quarters · filed 2021-03-01 | -$45.02M derived: sum of 3 quarters · filed 2021-03-01 | -$82.44M derived: sum of 4 quarters · filed 2021-03-01 | |||||||||||||||||
| 2019-12-31 | -$11.20M 10-K · filed 2021-03-01 | -$28.08M derived: sum of 2 quarters · filed 2021-03-01 | -$65.51M derived: sum of 3 quarters · filed 2021-03-01 | -$75.59M 10-K · filed 2021-03-01 | |||||||||||||||||
| 2019-09-30 | -$16.89M 10-K · filed 2021-03-01 | -$54.31M derived: sum of 2 quarters · filed 2021-03-01 | -$64.40M 10-Q · filed 2020-11-05 | -$95.09M derived: sum of 4 quarters · filed 2021-03-01 | |||||||||||||||||
| 2019-06-30 | -$37.42M 10-K · filed 2021-03-01 | -$47.51M 10-Q · filed 2020-08-06 | -$78.20M derived: sum of 3 quarters · filed 2021-03-01 | -$92.41M derived: sum of 4 quarters · filed 2021-03-01 | |||||||||||||||||
| 2019-03-31 | -$10.09M 10-K · filed 2021-03-01 | -$40.78M derived: sum of 2 quarters · filed 2021-03-01 | -$54.98M derived: sum of 3 quarters · filed 2021-03-01 | -$99.32M derived: sum of 4 quarters · filed 2021-03-01 | |||||||||||||||||
| 2018-12-31 | -$30.69M 10-K · filed 2021-03-01 | -$44.90M derived: sum of 2 quarters · filed 2021-03-01 | -$89.23M derived: sum of 3 quarters · filed 2021-03-01 | -$113.58M 10-K · filed 2021-03-01 | |||||||||||||||||
| 2018-09-30 | -$14.20M 10-K · filed 2021-03-01 | -$58.54M derived: sum of 2 quarters · filed 2021-03-01 | -$82.88M 10-Q · filed 2019-11-07 | -$146.96M derived: sum of 4 quarters · filed 2021-03-01 | |||||||||||||||||
| 2018-06-30 | -$44.34M 10-K · filed 2021-03-01 | -$68.68M 10-Q · filed 2019-08-09 | -$132.76M derived: sum of 3 quarters · filed 2021-03-01 | -$209.94M derived: sum of 4 quarters · filed 2021-03-01 | |||||||||||||||||
| 2018-03-31 | -$24.34M 10-K · filed 2021-03-01 | -$88.42M derived: sum of 2 quarters · filed 2021-03-01 | -$165.60M derived: sum of 3 quarters · filed 2021-03-01 | -$243.44M derived: sum of 4 quarters · filed 2021-03-01 | |||||||||||||||||
| 2017-12-31 | -$64.08M 10-K · filed 2020-02-28 | $64.08M 10-K · filed 2018-03-09 | -$141.26M derived: sum of 2 quarters · filed 2020-02-28 | -$219.09M derived: sum of 3 quarters · filed 2020-02-28 | -$291.95M 10-K · filed 2020-02-28 | ||||||||||||||||
| 2017-09-30 | -$77.18M 10-K · filed 2020-02-28 | -$155.01M derived: sum of 2 quarters · filed 2020-02-28 | -$227.88M 10-Q · filed 2018-11-05 | -$300.54M derived: sum of 4 quarters · filed 2020-02-28 | |||||||||||||||||
| 2017-06-30 | -$77.83M 10-K · filed 2020-02-28 | -$150.70M 10-Q · filed 2018-08-09 | -$223.36M derived: sum of 3 quarters · filed 2020-02-28 | -$289.14M derived: sum of 4 quarters · filed 2020-02-28 | |||||||||||||||||
| 2017-03-31 | -$72.86M 10-K · filed 2020-02-28 | -$145.53M derived: sum of 2 quarters · filed 2020-02-28 | -$211.31M derived: sum of 3 quarters · filed 2020-02-28 | -$277.90M derived: sum of 4 quarters · filed 2020-02-28 | |||||||||||||||||
| 2016-12-31 | -$72.66M 10-K · filed 2019-03-01 | -$138.44M derived: sum of 2 quarters · filed 2019-03-01 | -$205.04M derived: sum of 3 quarters · filed 2019-03-01 | -$276.01M 10-K · filed 2019-03-01 | |||||||||||||||||
| 2016-09-30 | -$65.78M 10-K · filed 2019-03-01 | -$132.38M derived: sum of 2 quarters · filed 2019-03-01 | -$203.35M 10-Q · filed 2017-11-09 | -$265.07M derived: sum of 4 quarters · filed 2019-03-01 | |||||||||||||||||
| 2016-06-30 | -$66.60M 10-K · filed 2019-03-01 | -$137.57M 10-Q · filed 2017-08-09 | -$199.29M derived: sum of 3 quarters · filed 2019-03-01 | -$259.70M derived: sum of 4 quarters · filed 2019-03-01 | |||||||||||||||||
| 2016-03-31 | -$70.97M 10-K · filed 2019-03-01 | -$132.69M derived: sum of 2 quarters · filed 2019-03-01 | -$193.11M derived: sum of 3 quarters · filed 2019-03-01 | -$257.80M derived: sum of 4 quarters · filed 2019-03-01 | |||||||||||||||||
| 2015-12-31 | -$61.72M 10-K · filed 2018-03-09 | -$122.14M derived: sum of 2 quarters · filed 2018-03-09 | -$186.83M derived: sum of 3 quarters · filed 2018-03-09 | -$239.28M 10-K · filed 2018-03-09 | |||||||||||||||||
| 2015-09-30 | -$60.42M 10-K · filed 2018-03-09 | -$125.11M derived: sum of 2 quarters · filed 2018-03-09 | -$177.56M 10-Q · filed 2016-11-09 | -$225.05M derived: sum of 4 quarters · filed 2018-03-09 | |||||||||||||||||
| 2015-06-30 | -$64.69M 10-K · filed 2018-03-09 | -$117.15M 10-Q · filed 2016-08-09 | -$164.63M derived: sum of 3 quarters · filed 2018-03-09 | -$200.47M derived: sum of 4 quarters · filed 2018-03-09 | |||||||||||||||||
| 2015-03-31 | -$52.45M 10-K · filed 2018-03-09 | -$99.94M derived: sum of 2 quarters · filed 2018-03-09 | -$135.78M derived: sum of 3 quarters · filed 2018-03-09 | -$174.63M derived: sum of 4 quarters · filed 2018-03-09 | |||||||||||||||||
| 2014-12-31 | -$47.48M 10-K · filed 2017-03-01 | -$83.33M derived: sum of 2 quarters · filed 2017-03-01 | -$122.17M derived: sum of 3 quarters · filed 2017-03-01 | -$141.97M 10-K · filed 2017-03-01 | |||||||||||||||||
| 2014-09-30 | -$35.84M 10-K · filed 2017-03-01 | -$74.69M derived: sum of 2 quarters · filed 2017-03-01 | -$94.48M 10-Q · filed 2015-11-09 | -$110.43M derived: sum of 4 quarters · filed 2017-03-01 | -$233.73M 10-Q · filed 2014-11-10 | ||||||||||||||||
| 2014-06-30 | -$38.84M 10-K · filed 2017-03-01 | -$58.64M 10-Q · filed 2015-08-10 | -$74.58M derived: sum of 3 quarters · filed 2017-03-01 | -$88.87M derived: sum of 4 quarters · filed 2017-03-01 | -$197.89M 10-Q · filed 2014-08-11 | ||||||||||||||||
| 2014-03-31 | -$19.79M 10-K · filed 2017-03-01 | -$35.74M derived: sum of 2 quarters · filed 2017-03-01 | -$50.02M derived: sum of 3 quarters · filed 2017-03-01 | -$62.67M derived: sum of 4 quarters · filed 2017-03-01 | -$159.04M 10-Q · filed 2014-05-12 | ||||||||||||||||
| 2013-12-31 | -$15.95M 10-K · filed 2016-02-29 | -$30.23M derived: sum of 2 quarters · filed 2016-02-29 | -$42.88M derived: sum of 3 quarters · filed 2016-02-29 | -$54.66M 10-K · filed 2016-02-29 | -$139.25M 10-K · filed 2014-03-03 | ||||||||||||||||
| 2013-09-30 | -$14.28M 10-K · filed 2016-02-29 | -$26.93M derived: sum of 2 quarters · filed 2016-02-29 | -$38.71M 10-Q · filed 2014-11-10 | -$60.63M derived: sum of 4 quarters · filed 2016-02-29 | -$123.31M 10-Q · filed 2013-11-12 | ||||||||||||||||
| 2013-06-30 | -$12.65M 10-K · filed 2016-02-29 | -$24.43M 10-Q · filed 2014-08-11 | -$46.34M derived: sum of 3 quarters · filed 2016-02-29 | -$72.20M derived: sum of 4 quarters · filed 2016-02-29 | -$109.02M 10-Q · filed 2013-08-06 | ||||||||||||||||
| 2013-03-31 | -$11.78M 10-K · filed 2016-02-29 | -$33.69M derived: sum of 2 quarters · filed 2016-02-29 | -$59.55M derived: sum of 3 quarters · filed 2016-02-29 | -$74.31M derived: sum of 4 quarters · filed 2016-02-29 | -$96.37M 10-Q · filed 2013-05-09 | ||||||||||||||||
| 2012-12-31 | -$21.91M 10-K · filed 2015-03-02 | -$47.77M derived: sum of 2 quarters · filed 2015-03-02 | -$62.53M derived: sum of 3 quarters · filed 2015-03-02 | -$74.35M 10-K · filed 2015-03-02 | -$84.59M 10-K · filed 2013-04-01 | ||||||||||||||||
| 2012-09-30 | -$25.86M 10-K · filed 2015-03-02 | -$25.86M 10-Q · filed 2012-11-14 | -$40.61M derived: sum of 2 quarters · filed 2015-03-02 | -$52.44M 10-Q · filed 2013-11-12 | -$52.44M 10-Q · filed 2012-11-14 | -$62.29M derived: sum of 4 quarters · filed 2015-03-02 | -$62.68M 10-Q · filed 2012-11-14 | ||||||||||||||
| 2012-06-30 | -$14.75M 10-K · filed 2015-03-02 | -$14.75M 10-Q · filed 2012-08-14 | -$26.58M 10-Q · filed 2013-08-06 | -$26.58M 10-Q · filed 2012-08-14 | -$36.43M derived: sum of 3 quarters · filed 2015-03-02 | -$36.77M derived: sum of 4 quarters · filed 2015-03-02 | -$36.82M 10-Q · filed 2012-08-14 | ||||||||||||||
| 2012-03-31 | -$11.83M 10-K · filed 2015-03-02 | -$11.83M 10-Q · filed 2012-05-15 | -$21.67M derived: sum of 2 quarters · filed 2015-03-02 | -$22.02M derived: sum of 3 quarters · filed 2015-03-02 | -$22.06M derived: sum of 4 quarters · filed 2015-03-02 | -$22.07M 10-Q · filed 2012-05-15 | |||||||||||||||
| 2011-12-31 | -$9.85M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | -$10.19M derived: sum of 2 quarters · filed 2014-03-03 | -$10.23M derived: sum of 3 quarters · filed 2014-03-03 | -$10.23M 10-K · filed 2014-03-03 | -$10.23M 10-K · filed 2012-03-29 | -$10.24M 10-K · filed 2012-03-29 | |||||||||||||||
| 2011-09-30 | -$347.43K 10-Q · filed 2012-11-14 | -$381.70K derived: sum of 2 quarters · filed 2012-11-14 | -$385.64K 10-Q · filed 2012-11-14 | -$392.57K 10-Q · filed 2011-11-14 | |||||||||||||||||
| 2011-06-30 | -$34.27K 10-Q · filed 2012-08-14 | -$38.21K 10-Q · filed 2012-08-14 | -$45.21K derived: sum of 3 quarters · filed 2013-04-01 | -$51.84K derived: sum of 4 quarters · filed 2013-04-01 | |||||||||||||||||
| 2011-03-31 | -$3.94K 10-Q · filed 2012-05-15 | -$10.94K derived: sum of 2 quarters · filed 2013-04-01 | -$17.57K derived: sum of 3 quarters · filed 2013-04-01 | ||||||||||||||||||
| 2010-12-31 | -$7.00K 10-K · filed 2013-04-01 | -$6.93K 10-K · filed 2012-03-29 | -$13.63K derived: sum of 2 quarters · filed 2013-04-01 | ||||||||||||||||||
| 2010-09-30 | -$6.63K 10-Q · filed 2011-11-14 | -$6.63K 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |